It includes 80+ advanced biomarkers that assess metabolic health, inflammation, hormones, and nutrient statusfar beyond routine panels
A consultation with our Medical Director is required before starting GHK Cu
Suitable for controlled storage and handling in research environments
For individuals with immune conditions that impair fertility, this peptide could provide a novel avenue for intervention
Secondary applications with emerging evidence include wound healing in patients with non-healing tissue, hair follicle stimulation, and early-stage research into cardiac recovery effects following the 2026 human trial data on Thymosin Beta-4
The verdict on the outcome that matters most was flat: no benefit on all-cause death, a risk ratio of 0.96 with a confidence interval from 0.65 to 1.41, at moderate certainty (Ziganshina et al., Cochrane 2023)